Toggle light / dark theme

Blood pressure is one of the most important indicators of heart health, but it’s tough to frequently and reliably measure outside of a clinical setting. For decades, cuff-based devices that constrict around the arm to give a reading have been the gold standard. But now, researchers at The University of Texas at Austin and Texas A&M University have developed an electronic tattoo that can be worn comfortably on the wrist for hours and deliver continuous blood pressure measurements at an accuracy level exceeding nearly all available options on the market today.

“Blood pressure is the most important vital sign you can measure, but the methods to do it outside of the clinic passively, without a cuff, are very limited,” said Deji Akinwande, a professor in the Department of Electrical and Computer Engineering at UT Austin and one of the co-leaders of the project, which is documented in a new paper published today in Nature Nanotechnology.

High blood pressure can lead to serious heart conditions if left untreated. It can be hard to capture with a traditional blood pressure check because that only measures a moment in time, a single data point.

In a surprise finding, researchers have found that getting at least one flu shot makes it 40 percent less likely for people over the age of 65 to be diagnosed with Alzheimer’s disease, up to four years later.

While it’s still far too early to determine if there are any direct causal links between the common vaccine and neurological health outcomes like Alzheimer’s — in other words, we don’t know if it’s the flu vaccine itself or something else responsible for the results — the research is certainly an eyebrow-raising new development that could, potentially, point in the direction of easily accessible treatments.

In a peer-reviewed study in the Journal of Alzheimer’s Disease, researchers at UTHealth Houston compared the incidence rate of the disease in patients with and without at least one flu vaccination in a nationwide sample of US adults aged 65 and up, which included 935,887 vaccinated and 935,887 non-vaccinated individuals.

Leading bipartisan moonshots for health, national security & functional government — senator joe lieberman, bipartisan commission on biodefense, no labels, and the centre for responsible leadership.


Senator Joe Lieberman, is senior counsel at the law firm of Kasowitz Benson Torres (https://www.kasowitz.com/people/joseph-i-lieberman) where he currently advises clients on a wide range of issues, including homeland and national security, defense, health, energy, environmental policy, intellectual property matters, as well as international expansion initiatives and business plans.

Prior to joining Kasowitz, Senator Lieberman, the Democratic Vice-Presidential nominee in 2000, served 24 years in the United States Senate where he helped shape legislation in virtually every major area of public policy, including national and homeland security, foreign policy, fiscal policy, environmental protection, human rights, health care, trade, energy, cyber security and taxes, as well as serving in many leadership roles including as chairman of the Committee on Homeland Security and Government Affairs.

Prior to being elected to the Senate, Senator Lieberman served as the Attorney General of the State of Connecticut for six years. He also served 10 years in the Connecticut State Senate, including three terms as majority leader.

In addition to practicing law, Senator Lieberman is honorary national founding chair of No Labels (https://www.nolabels.org/), an American political organization composed of Republicans, Democrats and Independents whose mission is to “usher in a new era of focused problem solving in American politics.”

Patients with worsening heart failure who received colchicine, a common gout medication, had a survival rate of 97.9% compared with a 93.5% survival rate for patients who did not take colchicine.

Colchicine, a common gout medication, dramatically increased the survival rates of patients with worsening heart failure who were hospitalized, according to a recent University of Virginia (UVA) Health study. In individuals with an accumulation of cholesterol in their arteries, the researchers think colchicine might also lower the risk for heart attack and stroke.

More than 1,000 patients who were hospitalized at the University of Virginia Medical Center between March 2011 and February 2020 due to worsening heart failure had their records examined. Patients who took colchicine for a gout flare had a survival rate of 97.9%, as opposed to patients who did not receive colchicine, who had a survival rate of 93.5%.

As cyberattacks on medical networks continue to affect healthcare institutions across the country, organizations who are directly at risk of these attacks are seeking government assistance.

From January through June, the Office of Civil Rights tallied 256 hacks and information breaches, up from 149 for the same period a year ago. It’s a continuing trend from last year: Cybersecurity outfit Sophos reports that in 2021, attacks on health systems were up 66 percent over 2020.

Now some health systems are asking the federal government to step in and provide more security for what they consider critical national infrastructure.

Artificial Intelligence is touching almost every aspect of our lives. It’s reasonable to expect AI influence will only increase in the future. One of many fields heavily influenced by AI is the military. Particularly in the development of Supersoldiers. The notion of super-soldiers enhanced with biotechnology and cybernetics was once only possible in the realm of science fiction. But it may not be too long before these concepts become a reality.

A new worldwide arms race is pitting countries against each other to be the first to successfully create real genetically modified super soldiers by using tools such as CRISPR. Understandably many of these human enhancement technologies raise health and safety questions and it is more likely these enhancements will first gain traction in countries that do not place as much weight on ethical concerns.

According to US Intelligence, China has conducted “human testing” on members of the People’s Liberation Army in hope of developing soldiers with “biologically enhanced capabilities.

This has made the U.S. military’s top intelligence agencies increasingly worried but the Pentagon has significantly invested in its own research in AI and in the extension of the human senses beyond their current physical limitations, to provide soldiers with superhuman abilities.

The basics of brain-machine interfaces with AI are being developed for the military, and if the results are as successful as scientists hope they will be, soldiers could one day be enhanced with cybernetics, effectively becoming trans-human soldiers.

The US Military is also examining newly scientific tools, like genetic engineering, brain chemistry, and shrinking robotics, for even more dramatic enhancements. But most of this advanced technology remains classified.

Latin Foods Market issued a recall for an Artri King joint supplement, as it contains undeclared diclofenac and dexamethasone.


The US Food and Drug Administration (FDA) published a health warning in mid-April concerning Artri King-branded products. The company makes a pain reliever available as a supplement for joint pain and arthritis. However, FDA testing discovered that Artri King products contain hidden drug ingredients, including diclofenac and dexamethasone.

Walmart already recalled Artri King products in late May, and now Latin Foods Market is following suit with a new recall of its own.

Walmart’s joint supplement recall concerned various Artri King products that may contain undeclared diclofenac. The Latin Foods Market recall covers just one Artri King product that can contain both diclofenac and dexamethasone.

It’s a given that certain bacteria and viruses can cause illness and disease, but the real culprits are the sequences of concern that lie within the genomes of these microbes.

Calling them out is about to get easier.

Years of work by Rice University computer scientists and their colleagues have led to an improved platform for DNA screening and pathogenic sequence characterization, whether naturally occurring or synthetic, before they have the chance to impact public health.

Researching Non-Specific Vaccine Effects For Human Health Benefit — Prof. Dr. Christine Stabell Benn, MD, PhD, DMSc, University Of Southern Denmark


Prof. Dr. Christine Stabell Benn, MD, PhD, DMSc, (https://portal.findresearcher.sdu.dk/en/persons/cbenn), is a physician, a professor of global health at the University of Southern Denmark, and a vaccine researcher with almost thirty years of experience in the field, where the focus of her research is “non-specific vaccine effects”, defined as all those other effects, both positive and negative, that vaccines have on our immune systems and overall health, beyond their very specific ability to protect against a specific infectious disease.

Prof. Dr. Stabell Benn has her medical degree, PhD, and Doctor of Medical Science from University of Copenhagen and has been responsible for planning, executing and publishing epidemiological and immunological studies of health interventions internationally, as well as supervising a number of pre-and postgraduate/PhD students.

Prof. Dr. Stabell Benn started working as a medical student in 1993 at the Bandim Health Project (https://www.bandim.org/), a population based health research project in one of the world’s poorest countries, Guinea-Bissau, developing a health and demographic surveillance system of over 100,000 people. She spent postdoc time at the Danish National Hospital, Department for Infectious Diseases and at Stanford University.

In 2012, Dr. Benn was selected by the Danish National Research Foundation to establish and lead a Center of Excellence, the “Research Center for Vitamins and Vaccines” (CVIVA — www.cviva.dk).

Stress – whether it’s job strain, emotional wrangles or health worries – is something we all experience. However, a new study from USC shows stress accelerates aging of the immune system, potentially increasing a person’s risk of cancer, cardiovascular disease and illness from infections such as COVID-19 [1].

Longevity. Technology: The new research, which has been published in the Proceedings of the National Academy of Sciences, could help explain disparities in age-related health, including the unequal toll of the pandemic, and identify possible points for intervention.

“As the world’s population of older adults increases, understanding disparities in age-related health is essential. Age-related changes in the immune system play a critical role in declining health,” said lead study author Eric Klopack, a postdoctoral scholar in the USC Leonard Davis School of Gerontology. “This study helps clarify mechanisms involved in accelerated immune aging [2].”